METOJECT (Methotrexate Injection) (innovative drug)

Date:
2024-04-19
Category:
Indication
(1)For the treatment of severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, PUVA, and retinoids
(2)For the treatment of active rheumatoid arthritis in adult patients